Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider James Garner bought 1,500,000 shares of Percheron Therapeutics stock in a transaction on Tuesday, December 24th. The shares were acquired at an average cost of A$0.01 ($0.00) per share, with a total value of A$10,500.00 ($6,481.48).
James Garner also recently made the following trade(s):
- On Wednesday, November 27th, James Garner acquired 125,000 shares of Percheron Therapeutics stock. The shares were acquired at an average cost of A$0.07 ($0.04) per share, with a total value of A$8,875.00 ($5,478.40).
- On Thursday, November 14th, James Garner bought 375,000 shares of Percheron Therapeutics stock. The stock was bought at an average cost of A$0.08 ($0.05) per share, for a total transaction of A$30,000.00 ($18,518.52).
Percheron Therapeutics Price Performance
Percheron Therapeutics Company Profile
Featured Articles
- Five stocks we like better than Percheron Therapeutics
- There Are Different Types of Stock To Invest In
- 3 Stocks Helping to Bring AI to Healthcare
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.